» Articles » PMID: 26951882

Genetic Contribution of CYP1A1 Variant on Treatment Outcome in Epilepsy Patients: a Functional and Interethnic Perspective

Overview
Date 2016 Mar 9
PMID 26951882
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

CYP1A1 gene is involved in estrogen metabolism, and previously, we have reported association of variant rs2606345 with altered anti-epileptic drugs (AED) response in North Indian women with epilepsy (WWE). The present study aims to replicate the pharmacogenetic association, perform functional characterization and study its distribution within ethnically diverse Indian population. The variant was genotyped in 351 patients to assess the pharmacogenetic association and 552 healthy individuals belonging to 24 different ethnic groups to examine the distribution in Indian population. We observed significant overrepresentation of 'A' allele and 'AA' genotype in poor responders in WWE at Bonferroni-corrected significance levels. The recessive allele was found to lower the promoter activity by ~70-80% which was further substantiated by thermally less stable hairpin formed by it (ΔT=7 °C). Among all ethnic groups, west Indo-European (IE-W-LP2) subpopulation showed highest genotypic frequency of the variant making women from this community more prone to poor AED response. Our results indicate that rs2606345 influences drug response in WWE by lowering CYP1A1 expression.

Citing Articles

Exploratory focused pharmacogenetic testing reveals novel markers associated with risperidone pharmacokinetics in Saudi children with autism.

Shilbayeh S, Adeen I, Ghanem E, Aljurayb H, Aldilaijan K, AlDosari F Front Pharmacol. 2024; 15:1356763.

PMID: 38375040 PMC: 10875102. DOI: 10.3389/fphar.2024.1356763.


Association Between Polymorphisms and Esophageal Cancer Susceptibility: A Case-control Study.

Kaya Z, Gursoy S In Vivo. 2023; 37(2):868-878.

PMID: 36881057 PMC: 10026655. DOI: 10.21873/invivo.13155.


Pharmacogenetics-based population pharmacokinetic analysis and dose optimization of valproic acid in Chinese southern children with epilepsy: Effect of gene polymorphism.

Shen X, Chen X, Lu J, Chen Q, Li W, Zhu J Front Pharmacol. 2022; 13:1037239.

PMID: 36506519 PMC: 9733833. DOI: 10.3389/fphar.2022.1037239.


Human genetic factors associated with pneumonia risk, a cue for COVID-19 susceptibility.

Guin D, Yadav S, Singh P, Singh P, Thakran S, Kukal S Infect Genet Evol. 2022; 102:105299.

PMID: 35545162 PMC: 9080029. DOI: 10.1016/j.meegid.2022.105299.


Precision medicine in women with epilepsy: The challenge, systematic review, and future direction.

Li Y, Zhang S, Snyder M, Meador K Epilepsy Behav. 2021; 118:107928.

PMID: 33774354 PMC: 8653993. DOI: 10.1016/j.yebeh.2021.107928.


References
1.
Shimada T, Yun C, Yamazaki H, GAUTIER J, Beaune P, Guengerich F . Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol. 1992; 41(5):856-64. View

2.
Grover S, Talwar P, Baghel R, Kaur H, Gupta M, Gourie-Devi M . Genetic variability in estrogen disposition: Potential clinical implications for neuropsychiatric disorders. Am J Med Genet B Neuropsychiatr Genet. 2010; 153B(8):1391-410. DOI: 10.1002/ajmg.b.31119. View

3.
Puglisi J, Tinoco Jr I . Absorbance melting curves of RNA. Methods Enzymol. 1989; 180:304-25. DOI: 10.1016/0076-6879(89)80108-9. View

4.
Kypr J, Vorlickova M . Graphical analysis of circular dichroic spectra distinguishes between two-state and gradual alterations in DNA conformation. Gen Physiol Biophys. 1986; 5(4):415-21. View

5.
Ward L, Kellis M . HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2011; 40(Database issue):D930-4. PMC: 3245002. DOI: 10.1093/nar/gkr917. View